Picard Medical (PMI) FCF Margin (2024 - 2026)

Picard Medical has reported FCF Margin for 3 years, with the latest figure at 332.7% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 2876.0% year-over-year to 332.7%; the trailing twelve-month figure through Mar 2026 stood at 315.1% (down 5113.0% YoY), and the FY2025 full-year result was 317.27%, down 4685.0% from the prior year.
• FCF Margin for Q1 2026 stood at 332.7%, up from 433.8% in the prior quarter.
• The five-year high for FCF Margin was 119.24% in Q2 2025, with the low at 548.78% in Q3 2025.
• Historically, FCF Margin has averaged 352.72% across 3 years, with a median of 361.45% in 2025.
• Annual changes were most pronounced in 2025 — FCF Margin tumbled 25275 bps — and 2026, when it soared 2876 bps.
• Picard Medical's FCF Margin stood at 377.03% in 2024, then dropped by 15 bps to 433.8% in 2025, then gained by 23 bps to 332.7% in 2026.
• The last three FCF Margin figures came in at 332.7% (Q1 2026), 433.8% (Q4 2025), and 548.78% (Q3 2025), per Business Quant data.